Abstract

Room Temperature Stability of Injectable Succinylcholine Dichloride

Author(s): Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice

Issue: Jan/Feb 2008 - Compounding for Hospice and Cancer Patients

Page(s): 83-85

Download in electronic PDF format for $75
  • Room Temperature Stability of Injectable Succinylcholine Dichloride Page 1
  • Room Temperature Stability of Injectable Succinylcholine Dichloride Page 2
  • Room Temperature Stability of Injectable Succinylcholine Dichloride Page 3

Abstract

The purpose of this study was to determine the room temperature stability over a period of several months of commercially available intravenous succinylcholine dichloride (Quelicin, 20 mg/mL) in vials. A previously validated electrospray tandem mass spectrometry method developed for the determination of succinylcholine dichloride in plasma was used. This method was based upon a stable isotope dilution assay using hexadeuterosuccinylcholine diiodide as the internal standard and was shown to be specific, sensitive, and reproducible. Calibration curves were plots of the ratios of intensities of the major product ions in the collision-induced dissociation spectrum for known concentration ratios of succinylcholine dichloride and hexadeuterosuccinylcholine diiodide in solutions. The concentration of succinylchloline dichloride was shown to decline linearly. After 1, 3, and 6 months at room temperature, the vial contents retained approximately 98%, 95%, and 90% of their initial concentrations, respectively. We sugge

Related Keywords

  • succinylcholine dichloride
  • intravenous preparation
  • parenteral administration
  • drug stability
  • neuromuscular depolarizing blocking agent
  • endotracheal intubation
  • muscle relaxant
  • skeletal muscle relaxation

Related Categories

  • PARENTERALS
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • MUSCULOSKELETAL DISORDERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2008
Pg. 83-85
Room Temperature Stability of Injectable Succinylcholine Dichloride
Author(s): Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
Mar/Apr 2008
Pg. 156-160
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 68-70
Stability of Succinylcholine Chloride Injection at Ambient Temperature and 4 Degree C in Polypropylene Syringes
Author(s): Storms Meredith L, Stewart James T, Warren Flynn W
Jul/Aug 2013
Pg. 335
Succinylcholine Chloride 50-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Author(s): Allen Loyd V Jr
Jul/Aug 2019
Pg. 281-287
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Author(s): Newton David W
Jan/Feb 2017
Pg. 76-82
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride
Author(s): Wu George, Yeung Stanley, Chen Frank
Jan/Feb 2018
Pg. 86-94
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Mar/Apr 2021
Pg. 131-139
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 339-346
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4
Author(s): de Oliveira Ferreira Anderson, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
May/Jun 2009
Pg. 254-258
Stability of Pergolide Mesylate Oral Liquid at Room Temperature
Author(s): Shank Brandon R, Ofner Clyde M III
Jan/Feb 2017
Pg. 66-75
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate
Author(s): Wu George, Yeung Stanley, Chen Frank
May/Jun 2021
Pg. 222-229
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 446-462
Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021
Author(s): Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
Sep/Oct 2014
Pg. 427-431
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Author(s): Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
May/Jun 2023
Pg. 223-229
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 31-38
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 52-61
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Author(s): Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T